SB3560 (Closing the Contraception Coverage Gap Act) amends Title XVIII of the Social Security Act to add a statutory definition of “contraceptive items and services,” require Medicare coverage of those items with no beneficiary cost-sharing, and change payment rules across Parts B, C (Medicare Advantage), and D. The definition incorporates patient-centered counseling and ancillary clinical services (device insertion/removal, follow-up, management of side effects) and instructs HHS to align guidance with the January 12, 2022 Public Health Service Act guidance.
The bill phases these changes in for plan years and services furnished on or after January 1, 2027.
The bill changes how Medicare pays for these services (including a Part B payment rule that requires Medicare to cover 100% of the allowable charge or a Secretary‑set rate), removes Part D deductibles and cost‑sharing for contraceptive drugs identified under PHS guidance, and directs HHS and GAO to study access gaps—particularly for beneficiaries with disabilities and dual eligibles. For compliance officers, plan sponsors, and providers, SB3560 creates new coverage mandates, payment formulas, and coordination duties that will require administrative updates to benefits, formularies, billing, and state‑federal coordination procedures.
At a Glance
What It Does
The bill adds a statutory category—"contraceptive items and services"—that includes counseling and ancillary clinical care, and requires Medicare to provide those items with no beneficiary cost‑sharing under Parts B, C, and D beginning January 1, 2027 (for plan years). It instructs the Secretary to pay Part B claims at 100% of the lesser of actual charge or a Secretary‑determined payment basis and removes deductibles and coinsurance for specified Part D contraceptive drugs.
Who It Affects
Directly affects Medicare beneficiaries who need contraceptive care (including those enrolled in Original Medicare, Medicare Advantage, and Part D), clinicians who furnish contraception and related services, Medicare Advantage organizations and Part D sponsors that must redesign benefits and formularies, and state Medicaid programs when coordinating coverage for dual eligibles.
Why It Matters
The measure closes a documented coverage gap between commercial preventive rules and Medicare, shifting costs and administrative responsibility to federal programs. It will change provider billing and Part D formulary management, require interagency reviews of dual‑eligible coverage, and could alter Medicare spending trajectories depending on HHS’s payment and guidance choices.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
SB3560 creates a new, explicit statutory category in Medicare law called “contraceptive items and services.” That definition does two important things: it incorporates the scope of services reflected in prior HHS guidance (including patient‑centered counseling) and it expressly includes ancillary clinical services—such as device insertion and removal, ultrasounds, follow‑up visits, and management of side effects—so that the clinical package around contraception is in scope, not just the drug or device.
On payment and cost‑sharing, the bill requires Medicare to eliminate beneficiary cost‑sharing for these services. For Part B it amends payment rules so that Medicare pays an amount equal to 100% of the lesser of the provider’s actual charge or a payment basis the Secretary determines appropriate; the deductible also will not apply.
For Part D the bill forces plans to identify covered contraceptive drugs consistent with PHS guidelines and bars deductibles, coinsurance, or other cost‑sharing for those drugs in plan years beginning January 1, 2027, with parallel changes for low‑income subsidy rules.Medicare Advantage plans must include contraceptive items and services as a covered benefit without cost‑sharing for plan years beginning January 1, 2027, which will require benefit redesign and possible premium or rebate adjustments. The bill also instructs HHS to develop guidance on patient‑centered counseling and authorizes the Secretary to develop quality measures for contraceptive counseling and access, which could feed into performance monitoring over time.Finally, SB3560 builds in a sequence of analyses: HHS must study access to prescription drug coverage (including oral contraceptives) for beneficiaries with disabilities enrolled only in Original Medicare and report back within a year, and the Government Accountability Office must report on types of plans not required to cover or waive cost‑sharing for contraception and on coverage differences for dual eligibles—with deadlines at one and two years.
Those studies create a legislative path to address gaps not solved by the statutory amendments themselves.
The Five Things You Need to Know
The bill defines “contraceptive items and services” in new section 1861(nnn) to include patient‑centered counseling (aligned to Jan 12, 2022 PHS guidance) and ancillary clinical services such as device insertion, removal, ultrasounds, pain management, follow‑up and side‑effect management.
For Part B services the bill amends section 1833(a) so Medicare must pay 100% of the lesser of the provider’s actual charge or a Secretary‑determined payment basis for contraceptive items and services, and the Part B deductible will not apply.
Part D sponsors must identify and cover contraceptive drugs called out in PHS guidance; for plan years beginning Jan 1, 2027 the bill eliminates deductibles, coinsurance, and other cost‑sharing for those drugs and aligns low‑income subsidy rules accordingly.
Medicare Advantage (Part C) is required to treat contraceptive items and services as a covered benefit without beneficiary cost‑sharing for plan years beginning Jan 1, 2027, forcing MA organizations to update benefits and formularies.
The bill directs studies and reports: HHS must report within 1 year on drug access for beneficiaries with disabilities and OTC coverage; GAO must report within 1 year on plan types not required to cover contraception and within 2 years on coverage differences for dual eligibles, with legislative recommendations.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Names the bill the "Closing the Contraception Coverage Gap Act." This is purely stylistic but signals legislative intent to eliminate a coverage disparity for contraceptive care in Medicare.
Definition and scope of covered contraceptive services
Adds a detailed statutory definition that ties coverage scope to existing Public Health Service guidance (Jan 12, 2022) and explicitly includes patient‑centered counseling and a set of ancillary clinical services (insertion/removal, ultrasound, pain management, follow‑up, side‑effect management). Importantly, the bill says these services are covered regardless of whether they are furnished expressly for contraception, which broadens clinical scenarios in which Medicare must cover the item or service. For implementation this means HHS will need to translate the definition into billing codes and guidance for clinicians and suppliers.
100% payment rule and deductible exclusion
Modifies Medicare’s payment framework so that contraceptive items and services billed under Part B are paid at 100% of the lesser of actual charge or a payment basis set by the Secretary, and clarifies that the deductible does not apply. Practically, this creates a new payment category requiring CMS to decide an appropriate payment basis, update fee schedules or claim adjudication logic, and communicate any new billing modifiers to providers.
MA plans must cover contraceptives without cost‑sharing
Amends the MA rules to list contraceptive items and services as a required benefit category for plan years beginning January 1, 2027. MA organizations will have to revise plan benefits, update member materials and provider networks, and may face premium or rebate changes to accommodate benefit costs. CMS will need to provide guidance on benefit design, network adequacy, and how these services interact with MA quality and utilization review processes.
Part D formulary identification and elimination of cost‑sharing
Directs Part D to identify covered contraceptive drugs consistent with PHS guidance and removes deductibles and coinsurance for those drugs in plan years beginning Jan 1, 2027; it also makes conforming changes for low‑income subsidy rules. Plan sponsors must modify formularies, benefit structures, and claims systems; CMS must update PDP and MAPD guidance on exceptions, prior authorization, and potential impacts on negotiated prices and rebates.
Comparability requirement and mandated studies/reports
Requires the Secretary to ensure contraceptive coverage for dual eligibles is at least as comprehensive as state Medicaid coverage, based on annual reviews—an operational coordination task that could require new data exchanges with states. It also instructs HHS to study access to prescription drugs for beneficiaries with disabilities and to consider OTC coverage options (report due in 1 year) and orders two GAO studies: one on insurance types not required to cover or waive cost‑sharing for contraception (report due in 1 year) and one on coverage differences for dual eligibles (report due in 2 years). These studies are designed to surface gaps and possible legislative fixes beyond the statute’s immediate changes.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Medicare beneficiaries of reproductive age, including people who use contraceptive drugs and devices — they would face no cost‑sharing for a defined package of contraceptive care, lowering out‑of‑pocket barriers.
- People with disabilities enrolled in Medicare fee‑for‑service who rely on prescription contraceptives — the bill prompts an HHS study and may lead to expanded drug access options, potentially benefiting those currently paying out of pocket.
- Clinicians and family‑planning providers (OB/GYNs, primary care, community health clinics) — clearer billing rules and guaranteed payment for a broader scope of services (including insertion/removal and follow‑up) reduce patient collection risk and can improve treatment planning.
- Dual eligibles (Medicare–Medicaid) — the Secretary must ensure Medicare’s coverage is at least as comprehensive as state Medicaid for these services, which could reduce gaps or surprise cost‑sharing for duals.
- Low‑income Medicare beneficiaries enrolled in Part D low‑income subsidy programs — the bill’s conforming amendments remove cost‑sharing for qualifying contraceptive drugs, reducing direct costs.
Who Bears the Cost
- Federal Medicare program and ultimately taxpayers — removing cost‑sharing and adding covered services will increase federal outlays for Part B, Part D, and MA payments relative to current law.
- Medicare Advantage organizations and Part D sponsors — eliminating beneficiary cost‑sharing and adjusting formularies may pressure plan economics, forcing premium, rebate, or benefit design changes to offset costs.
- Plan and payer operations (claims processors, PBMs, MA compliance teams) — benefit redesign, formulary updates, new nondiscrimination or comparability checks for duals, and coding guidance will impose administrative implementation costs.
- State Medicaid agencies — the Secretary must compare and align Medicare coverage with state plans for duals, requiring state‑federal data exchanges and potential policy adjustments or disputes about which program is primary.
- Providers and clinics during the transition — while payment is guaranteed, providers will need to update billing practices, accept new payment bases, and manage any gaps while CMS issues guidance, which may create temporary cash‑flow or compliance burdens.
Key Issues
The Core Tension
The central tension is between guaranteeing no‑cost access to comprehensive contraceptive care (including counseling and ancillary services) and controlling federal spending and administrative complexity: expanding coverage improves access and aligns Medicare with preventive‑care norms, but it creates open questions about payment levels, fiscal impact, scope over time (given the tie to an earlier guidance), and the administrative burden of coordinating benefits across Original Medicare, MA, Part D, and state Medicaid programs for dual eligibles.
The bill’s reliance on prior HHS guidance (the Jan 12, 2022 PHS Act guidance) anchors coverage to a snapshot in time. That linkage simplifies scope‑setting in the short term but raises a practical question: will HHS update or reinterpret that guidance to reflect new FDA approvals, OTC switches, or changing clinical standards?
Tying statutory coverage to existing guidance reduces immediate ambiguity but requires CMS rule‑making or updated guidance to cover innovations or changes in standard practice.
Payment and budget trade‑offs are unresolved. The Part B payment amendment requires Medicare to cover 100% of the lesser of actual charge or a Secretary‑determined rate, but leaves the Secretary discretion to set that payment basis.
If CMS sets rates low, providers could face constrained reimbursement for resource‑intensive services (procedures, device insertions). If rates are set high, Medicare spending will rise.
The bill also expands coverage "regardless of whether actually furnished for purposes of contraception," which broadens fiscal exposure for services used for other clinical reasons.
Operationally, integrating these changes across Original Medicare, Medicare Advantage, Part D formularies, and state Medicaid plans for dual eligibles is complex. CMS must update claims processing logic, provider billing guidance, MA/Part D contract guidance, and data exchange protocols with states to evaluate comparability.
The bill requires quality measure development but leaves adoption optional and uncoupled from payment or star rating incentives, which may blunt the measures’ influence without further regulatory action.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.